Company profilePharmaceutical#45 of 1,318 in Pakistan✓ No DRAP alerts

REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD.

Pharmaceutical company · 253 brands · 203 molecules

Ranked #3 of 23 companies in Eye Conditions

253 registered products 89 pharmaceutical brands 203 distinct molecules 0 DRAP alerts

Company overview

253
registered products
89
pharmaceutical brands
203
distinct molecules
12
therapeutic classes
0
DRAP alerts

REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 253 product registrations across 203 distinct molecules. It is the 45th largest registrant in Pakistan by product count, and ranks 3rd of 23 in Eye Conditions. Its portfolio is concentrated in Eye Conditions and Antiinflammatory Agents And Antiinfectives In Combination. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by REMINGTON

142 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

100
ceilings with an approval date
46
not revised in 2+ years
2024
oldest approval year
202446
202551
20263
Longest without revision

Top molecules by brand count

Eye52 brands
Ear12 brands
Dexamethasone11 brands
Ciprofloxacin10 brands
Polymyxin B10 brands
Neomycin8 brands
Prednisolone7 brands
Artemether6 brands
Ofloxacin6 brands

Therapeutic classes

Eye Conditions · 18Antiinflammatory Agents And Antiinfectives In Combination · 13Anti-Infective, Ophthalmologicals · 12Otologicals · 8Decongestants And Antiallergics · 6Antiglaucoma Preparations And Miotics · 5Antiinflammatory Agents, Corticosteroids · 5Mydriatics And Cycloplegics · 4Antiinflammatory And Antirheumatic Products · 3Quinolone Antibacterials · 3Nasal Preparations · 3Ear Conditions · 2

Conditions treated

Allergy/Infections · 11Dry Eye/Allergy · 4Infection/Pain · 2Glaucoma/Mydriasis · 2Nasal Congestion · 2PAIN · 1General Infections · 1Eczema/Psoriasis/Dermatitis · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official149 products · Rs 18.22 – Rs 5,098.44
DVAGO20 products · Rs 34.7 – Rs 902.5
Servaid26 products · Rs 17.87 – Rs 450
Median across source: Rs 223.25

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Atco Pharma International (Pvt) Ltd holds 198 molecules not in this portfolio
Acetylsalicylic AcidAdapaleneAdapleneAlbuterolAminophyllineAmlodipine 6.95Mg Amlodipine Base
Sante (Private) Limited holds 49 molecules not in this portfolio
Azithromycin Azithromycin DihydarteBenzoyl PeroxideBetamethasoneCalciumChloroquineClindamycin
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 132 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipine BaseAmmonium ChlorideAmmonium Chloride Containing Expectorants

Get the full profile for REMINGTON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.